Understanding how certain DNA elements contribute to Alzheimer's disease and related dementias
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
This study is looking at how a protein called TDP-43 and certain DNA sequences in our genes might play a role in the worsening of Alzheimer's disease, with the hope that understanding these connections could help develop new treatments for people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11075233 on NIH RePORTER |
What this research studies
This research investigates the role of transposable elements and a specific protein called TDP-43 in the progression of Alzheimer's disease and related dementias. By examining how TDP-43 affects the accumulation of harmful proteins in the brain, the study aims to uncover new mechanisms that contribute to neurodegeneration. The approach involves analyzing the interactions between TDP-43 and transposable elements, which are repetitive DNA sequences that may influence brain health. Patients may benefit from insights gained that could lead to new therapeutic strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing cognitive decline.
Not a fit: Patients with early-stage cognitive impairment not yet diagnosed with Alzheimer's or related dementias may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Alzheimer's disease.
How similar studies have performed: Other research has shown promising results in understanding the role of TDP-43 in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Jin, Peng — Emory University
- Study coordinator: Jin, Peng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.